Our Technology
We make our blood smart and produce functional red blood cells
Our Proprietary Platform Delivers Drugs to Specific Targets
Our Technology is Applied in Three Areas.
Erythrocyte-based Nutraceuticals
Functionalized erythrocytes for the delivery of cancer vaccines
Delivering neurotrophic factor across the blood-brain barrier
We Innovate Based on Scientific Evidence
Hybrid erythrocyte liposomes: Functionalized red blood cell membranes for molecule encapsulation. Advanced Biosystems, 4(3), 1900185.
Erythro-VLPs: Anchoring SARS-CoV-2 spike proteins in erythrocyte liposomes. PLOS ONE, 17(3), p.e0263671.
Erythro-PmBs: A Specific Polymyxin B Delivery System Using Antibody-Conjugated Hybrid Erythrocyte Liposomes , in press ACS Infectious Diseases
Synth-Med Biotechnology Inc. Cline 65 Cline Avenue North, Hamilton, ON L8S 3Z5, Canada
Synth-Med 